Johnson Investment Counsel Inc Takeda Pharmaceutical CO LTD Transaction History

Johnson Investment Counsel Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$15.03 - $16.32 $7,289 - $7,915	-485 Reduced 4.42%	10,476 $162,000
Q2 2023 Aug 10, 2023	SELL	$15.57 - $17.11 $1,043 - $1,146	-67 Reduced 0.61%	10,961 $172,000
Q1 2023 May 15, 2023	SELL	$15.28 - $16.48 $3,835 - $4,136	-251 Reduced 2.23%	11,028 $181,000
Q4 2022 Feb 14, 2023	SELL	$12.42 - $15.62 $1,254 - $1,577	-101 Reduced 0.89%	11,279 $176,000
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $1,292 - $2,893	101 Added 0.9%	11,380 $148,000
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $13,198 - $15,120	1,006 Added 9.79%	11,279 $158,000
Q1 2022 May 11, 2022	SELL	$13.54 - $15.35 $5,416 - $6,140	-400 Reduced 3.75%	10,273 $147,000
Q4 2021 Feb 15, 2022	SELL	$13.17 - $16.4 $51,718 - $64,402	-3,927 Reduced 26.9%	10,673 $145,000
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $13,349 - $14,135	-819 Reduced 5.31%	14,600 $239,000
Q2 2021 Aug 13, 2021	SELL	$16.55 - $18.64 $6,255 - $7,045	-378 Reduced 2.39%	15,419 $266,000
Q1 2021 May 14, 2021	SELL	$16.71 - $19.9 $8,639 - $10,288	-517 Reduced 3.17%	15,797 $288,000
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $1,154 - $1,422	-75 Reduced 0.46%	16,314 $297,000
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $3,351 - $3,761	-196 Reduced 1.18%	16,389 $292,000
Q2 2020 Aug 13, 2020	BUY	$14.59 - $19.5 $1,167 - $1,560	80 Added 0.48%	16,585 $304,000
Q4 2019 Feb 13, 2020	BUY	$16.88 - $20.83 $3,376 - $4,166	200 Added 1.23%	16,505 $326,000
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $263,325 - $293,326	16,305 New	16,305 $280,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Johnson Investment Counsel Inc with notifications on news.